Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

HOPA 2018 | Benefits of performing outpatient transplant

Jeanne McCarthy-Kaiser • 21 Mar 2018
HOPA 2018
General

Speaking from the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference, held in Denver, CO, Jeanne McCarthy-Kaiser, PharmD, BCOP, of the University of Washington Medical Center, Seattle, WA, tells us about the benefits of outpatient transplant for both the patient and clinic.

More from Jeanne McCarthy-Kaiser

Patient education is important for drug tolerance and adherence
1:42
Patient education is important for drug tolerance and adherence
Jeanne McCarthy-Kaiser • 21 Mar 2018
The role of the pharmacist in transplant
1:52
The role of the pharmacist in transplant
Jeanne McCarthy-Kaiser • 21 Mar 2018

Related Videos

From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
2:58
From immunosuppression to targeted immunomodulation: emerging treatment strategies in GvHD
Iskra Pusic • 11 Sep 2026
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
3:46
Three-year survival update of pre-induction azacitidine and venetoclax in newly diagnosed AML
Maher Salamoon • 8 Sep 2026
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
2:01
Understanding the risks of lymphoproliferative disorders following CAR T-cell therapy
Michael Jain • 11 Sep 2026
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
1:46
Long-term survivorship after CAR T-cell therapy: addressing non-relapse mortality
Michael Jain • 11 Sep 2026
The content of VJHemOnc is intended for healthcare professionals